"Accenture continues to be a driving force in innovation, continuing a legacy in technology services with groundbreaking work ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

News of Nvidia CEO Jensen Huang presenting the keynote for CES 2025 could be a major hint for when Nvidia’s new flagship ...

Merck (NYSE:MRK) announced Tuesday that its Phase 3 KEYNOTE-689, designed to evaluate its anti-PD-1 therapy Keytruda as a ...

ARLINGTON, Va., Oct. 10, 2024 /PRNewswire/ -- The Consumer Technology Association (CTA) ®, owner and producer of CES ®, the world's most powerful tech event, announces Accenture Chair and CEO Julie ...

Known for his forward-thinking approach and passion for technology, Huang has been named the world's best CEO by Fortune and ...

The KEYNOTE-689 study evaluating pembrolizumab in this patient population met its primary end point of event-free survival.

Rahway, New Jersey Wednesday, October 9, 2024, 11:00 Hrs [IST] ...

It's been rumored for some time that the world's biggest tech trade show would be the launch pad for the Nvidia GeForce RTX ...

VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and enhance ...